References(43)
[1]
Falco-Walter, J. Epilepsy-Definition, Classification, Pathophysiology, and Epidemiology. Semin Neurol, 2020, 40(6): 617–623.
[2]
Tekgul, H., Simsek, E., Erdoğan, M. A., Yiğittürk, G., Erbaş, O., Taşkıran, D. The potential effects of anticonvulsant drugs on neuropeptides and neurotrophins in pentylenetetrazol kindled seizures in the rat. Int J Neurosci, 2020, 130(2): 193–203.
[3]
Sultana, B., Panzini, M. A., Veilleux Carpentier, A., Comtois, J., Rioux, B., Gore, G., Bauer, P. R., Kwon, C. S., Jetté, N., Josephson, C. B., Keezer, M. R. Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis. Neurology, 2021, 96(17): 805–817.
[4]
Löscher, W., Potschka, H., Sisodiy, a S. M., Vezzani, A. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options. Pharmacol Rev, 2020, 72(3): 606–638.
[5]
Melander, T., Hokfelt, T., Rokaeus, A.Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol, 1986, 248(4): 475–517.
[6]
Skofitsch, G., Jacobowitz, D. M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides, 1985, 6(3): 509–546.
[7]
Branchek, T., Smith, K. E., Walker, M. W. Molecular biology and pharmacology of galanin receptors. Ann N Y Acad Sci, 1998, 863: 94–107.
[8]
Mazarati, A.M., Halaszi, E., Telegdy, G. Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res, 1992, 589(1): 164–166.
[9]
Mazarati, A. M., Hohmann, J. G., Bacon, A., Liu, H., Sankar, R., Steiner, R. A., Wynick, D., Wasterlain, C. G. Modulation of hippocampal excitability and seizures by galanin. J Neurosci, 2000, 20(16): 6276–6281.
[10]
Kokaia, M., Holmberg, K., Nanobashvili, A., Xu, Z. Q., Kokaia, Z., Lendahl, U., Hilke, S., Theodorsson, E., Kahl, U., Bartfai, T., Lindvall, O., Hökfelt, T. Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci U S A, 2001, 98(24): 14006–14011.
[11]
Schlifke, I., Kuteeva, E., Hokfelt, T., Kokaia, M. Galanin expressed in the excitatory fibers attenuates synaptic strength and generalized seizures in the piriform cortex of mice. Exp Neurol, 2006, 200(2): 398–406.
[12]
McColl, C. D., Jacoby, A. S., Shine, J., Iismaa, T. P., Bekkers, J. M. Galanin receptor-1 knockout mice exhibit spontaneous epilepsy, abnormal EEGs and altered inhibition in the hippocampus. Neuropharmacology, 2006, 50(2): 209–218.
[13]
Mazarati, A., Lu, X., Shinmei, S., Badie-Mahdavi, H., Bartfai, T. Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice. Neuroscience, 2004, 128(2): 431–441.
[14]
Mazarati, A., Lu, X., Kilk, K., Langel, U., Wasterlain, C., Bartfai, T. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci, 2004, 19(12): 3235–3244.
[15]
Lu, X., Roberts, E., Xia, F., Sanchez-Alavez, M., Liu, T., Baldwin, R., Wu, S., Chang, J., Wasterlain, C. G., Bartfai, T. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proc Natl Acad Sci U S A, 2010, 107(34): 15229–15234.
[16]
Fetissov, S. O., Jacoby, A. S., Brumovsky,.PR., Shine,. J, Iismaa, T. P., Hökfelt, T. Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice. Epilepsia, 2003, 44(8): 1022–1033.
[17]
Glien, M., Brandt, C., Potschka, H., Voigt, H., Ebert, U., Loscher, W. Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy. Epilepsy Res, 2001, 46(2): 111–119.
[18]
Racine, R. J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol, 1972, 32(3): 281–294.
[19]
Xu, Z. Q., Shi, T. J., Hökfelt, T. Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. J Comp Neurol, 1998, 392(2): 227–251.
[20]
Bruxel, E. M., Bruno, D. C. F., do Canto, A. M., Geraldis, J. C., Godoi, A. B., Martin, M., Lopes-Cendes, I. Multi-omics in mesial temporal lobe epilepsy with hippocampal sclerosis: Clues into the underlying mechanisms leading to disease. Seizure, 2021, 90: 34–50.
[21]
Morimoto, K., Fahnestock, M., Racine, R. J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol, 2004, 73(1): 1–60.
[22]
Lin, E. J., Richichi, C., Young, D., Baer, K., Vezzani, A., During, M. J. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci, 2003, 18(7): 2087–2092.
[23]
Haberman, R. P., Samulski, R. J., McCown, T. J. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med, 2003, 9(8): 1076–1080.
[24]
McCown, T. J. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther, 2006, 14(1): 63–68.
[25]
Kanter-Schlifke, I., Toft, S. A., Ledri, M., Kuteeva, E., Hokfelt, T., Kokaia, M. Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity. Neuroscience, 2007, 150(4): 984–992.
[26]
Mazarati, A. M., Liu, H., Soomets, U., Sankar, R., Shin, D., Katsumori, H., Langel, U., Wasterlain, C. G. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci, 1998, 18(23): 10070–10077.
[27]
Wilson, D. N., Chung, H., Elliott, R. C., Bremer, E., George, D., Koh, S. Microarray analysis of postictal transcriptional regulation of neuropeptides. J Mol Neurosci, 2005, 25(3): 285–298.
[28]
Zini, S., Roisin, M.P., Langel, U., Bartfai, T., Ben-Ari, Y. Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur J Pharmacol, 1993, 245(1): 1–7.
[29]
Xu, Z. Q., Ma, X., Soomets, U., Langel, U., Hökfelt, T. Electrophysiological evidence for a hyperpolarizing, galanin (1-15)-selective receptor on hippocampal CA3 pyramidal neurons. Proc Natl Acad Sci U S A, 1999, 96(25): 14583–14587.
[30]
Hökfelt, T., Wiesenfeld-Hallin, Z., Villar, M., Melander, T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett, 1987, 83(3): 217–220.
[31]
Villar, M. J., Meister, B., Cortes, R., Schalling, M., Morris, M., Hokfelt, T. Neuropeptide gene expression in hypothalamic magnocellular neurons of normal and hypophysectomized rats: a combined immunohistochemical and in situ hybridization study. Neuroscience, 1990, 36(1): 181–199.
[32]
Cortes, R., Villar, M. J., Verhofstad, A., Hokfelt, T. Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc Natl Acad Sci U S A, 1990, 87(19): 7742–7746.
[33]
Li, Y., Mei, Z., Liu, S., Wang, T., Li, H., Li, X-X., Han, S., Yang, Y., Li, J., Xu, Z. Q. Galanin Protects from Caspase-8/12-initiated Neuronal Apoptosis in the Ischemic Mouse Brain via GalR1. Aging Dis, 2017, 8(1): 85–100.
[34]
Xu, Z. Q., Zheng, K., Hökfelt, T. Electrophysiological studies on galanin effects in brain-progress during the last six years. Neuropeptides, 2005, 39(3): 269–275.
[35]
Bai, Y. F., Ma, H.T., Liu, L. N., Li, H., Li, X. X., Yang, Y. T., Xue, B., Wang, D., Xu, Z. Q. D. Activation of galanin receptor 1 inhibits locus coeruleus neurons via GIRK channels. BiochemBiophys Res Commun, 2018, 503(1): 79–85.
[36]
Schauwecker, P.E. Galanin receptor 1 deletion exacerbates hippocampal neuronal loss after systemic kainate administration in mice. PLoS One, 2010, 5(12): e15657
[37]
Yang, Y., Li, Y., Liu, B., Li, C., Liu, Z., Deng, J., Luo, H., Li, X., Wu, J., Li, H., Wang, C.Y., Zhao, M., Wu, H., Lallemend, F., Svenningsson, P., Hökfelt, T. G. M., Xu,Z.Q.D.Involvement of Scratch2 in GalR1-mediated depression-like behaviors in the rat ventral periaqueductal gray. Proc Natl Acad Sci U S A, 2021, 118(24): e1922586118.
[38]
Kuteeva E., Hökfelt T., Wardi. T, Ogren S. O. Galanin, galanin receptor subtypes and depression-like behaviour. Exp Suppl, 2010, 102: 163–181.
[39]
Kim, A., Park, T. Diet-induced obesity regulates the galanin-mediated signaling cascade in the adipose tissue of mice. Mol Nutr Food Res, 2010, 54(9): 1361–1370.
[40]
Schmidhuber, S. M., Rauch, I., Kofler, B., Brain, S. D. Evidence that the modulatory effect of galanin on inflammatory edema formation is mediated by the galanin receptor 3 in the murine microvasculature. J Mol Neurosci, 2009, 37(2): 177–181.
[41]
Belfer, I., Hipp, H., Bollettino, A., McKnight, C., Evans, C., Virkkunen, M., Albaugh, B., Max, M. B., Goldman, D., Enoch, M. A. Alcoholism is associated with GALR3 but not two other galanin receptor genes. Genes Brain Behav, 2007, 6(5): 473–481.
[42]
Swanson, C. J., Blackburn, T. P., Zhang, X., Zheng, K., Xu, Z. Q., Hökfelt, T., Wolinsky, T. D., Konkel, M. J., Chen, H., Zhong, H., Walker, M. M., Durkin, M., Artymyshyn, R. P., Smith, K. E., Jones, K. J., Craig, D. A., Gerald, C. P., Brancheck, T. A. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci U S A, 2005, 102(48): 17489–17494.
[43]
Lu, X., Mazarati, A., Sanna, P., Shinmei, S., Bartfai, T. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity. Neuropeptides, 2005, 39(3): 147–152.